@article{TAU1261,
author = {Ferry ALM Eskens and Brigitte Haberkorn},
title = {Towards new treatment options for renal cell carcinoma: development and clinical results of tivozanib, a selective VEGFR tyrosine kinase inhibitor},
journal = {Translational Andrology and Urology},
volume = {1},
number = {4},
year = {2012},
keywords = {},
abstract = {Clear cell renal cancer (RCC) is the tumor in which the treatment paradigm of locally advanced and metastatic disease has almost completely shifted away from immunotherapy/cytokine treatment towards antiangiogenic therapies.},
issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/1261}
}